Variable (reference values) | Polypharmacy Age 65 + N = 399,227 R2 = 0.364 | HbA1c for those with diabetes N = 133,985 R2 = 0.1366 | 6 month childhood immunisations N = 26,859 R2 = 0.0795 | Child ASH admissions N = 511,845 R2 not applicable | Adult ASH admissions N = 655,088 R2 not applicable | ED attendances N = 2,500,000 R2 not applicable |
---|---|---|---|---|---|---|
Overall average | 38.2% | 86.9% | 75.6% | 31 per 1000 children | 38 per 1000 adults | 254 per 1000 patients |
Practice models | ||||||
Corporate (Traditional) | 37.5% (38.3%) | 86.3% (87.0%) | 74.3% (75.7%) | -9.3% | 20.9% *** | 1.4% |
PHO/DHB (Traditional) | 35.5% (38.3%) | 86.5% (86.9%) | 74.9% (75.6%) | -14.5% | 10.0% | 10.3% |
Trust/NGO (Traditional) | 38.1% (38.2%) | 88.4% (86.7%) | 79.3% (75.2%) | 38.3% ** | 31.5% *** | 15.4% ** |
HCH Practice (All others) | 38.7% (38.1%) | 86.2% (87.1%) | 78.5% (74.8%) *** | 5.6% | -5.4% | -11.2% *** |
Māori Practice (All others) | 34.7% (38.0%) * | 82.9% (87.0%) ** | 61.8% (76.4%) *** | -0.4% | 5.9% | 9.6% |
Pacific Practice (All others) | 36.9% (38.2%) | 83.6% (87.0%) | 66.5% (75.7%) * | -8.5% | -12.1% | -15.1% * |
Patient characteristics | ||||||
Male (Female) | 87.5% (86.2%) *** | 30.2% *** | ||||
Māori (Not Māori) | 37.8% (38.2%) | 85.5% (87.1%) *** | 68.4% (77.0%) *** | 28.1% *** | 27.4% *** | 20.8% *** |
Pacific (Not Pacific) | 34.2% (38.3%) *** | 85.5% (87.1%) *** | 76.1% (75.6) * | 40.2% *** | 28.0% *** | 19.5% *** |
Quintile 5 (Not Q5) | 86.3% (87.1%) *** | |||||
IMD (25th, 50th, 75th centiles) (ASH&ED ref: average IMD) | 36.0% *** 38.5% 41.0% | 78.1% *** 76.1% 73.9% | -11.2% *** 0.5% 13.1% | -10.5% *** 0.5% 11.4% | -8.2% *** 0.0% 8.9% | |
Diabetes (No diabetes) | 67.9% (32.9) *** | 20.4% *** | ||||
Gout (No gout) | 65.4% (35.7%) *** | 89.0% (86.5%) *** | 9.6% *** | |||
HbA1c (No HbA1c) | 40.8% (34.3%) *** | |||||
SSRI (No SSRI) | 59.1% (36.3%) *** | 36.5% *** | ||||
Antibiotic (No antibiotic) | 41.9% (35.2%) *** | 88.0% (85.6%) *** | 145.9% *** | 130.2% *** | 86.2% *** | |
Tramadol (No tramadol) | 58.2% *** | 173.9% *** | ||||
M3 (25th, 50th, 75th centiles) (ASH&ED ref: M3 = 0) | 34.9% *** 38.0% 44.1% | 88.3% *** 87.6% 86.3% | 19.3% *** 64.8% 256.6% | 20.4% *** 49.2% 118.6% | 13.8% *** 32.8% 77.5% | |
Continuity of practice (No continuity) | -24.3% *** | -18.9% *** | -20.2% *** | |||
Distance to Nearest ED (1, 20, 100 km) (ASH&ED ref: average distance) | 76.8% *** 74.9% 66.0% | 3.2% -1.3% -18.1% | 6.1% *** -3.0% -33.4% | |||
First Specialist Assessment (FSA 1, 2, 3) (ASH&ED ref: FSA = 0) | 39.8% *** 42.1% 44.3% | 87.8% *** 88.9% 90.0% | 45.9% *** 112.9% 210.7% | 45.1% *** 110.5% 205.5% | 46.1% *** 113.6% 212.2% | |
First Specialist Assessment Did Not Attend (FSA DNA 1, 2, 3) (ASH&ED ref: FSA DNA = 0) | 67.9% *** 58.9% 49.2% | 15.5% ** 33.4% 54.2% | 50.9% *** 127.6% 243.3% | 50.7% *** 127.2% 242.5% | ||
Practice characteristics | ||||||
VLCA (not VLCA) | 86.2% (87.3%) * | 74.1% (76.3%) * | ||||
Urban (Rural) | 38.1% (38.9%) | 86.7% (87.8%) * | 75.9% (73.6%) | -3.4% | -0.3% | |
Continuity of GP (25th, 50th, 75th centiles) (ASH&ED ref: Continuity = 0) | -6.6% *** -8.6% -12.7% | |||||
Primary care clinician input | ||||||
GP + NP consultations (Consultations 1, 2, 3) (ASH&ED ref: Consultations = 0) | 25.4% *** 28.3% 34.6% | 81.8% *** 83.1% 85.3% | 73.8% *** 74.3% 75.2% | 8.7% *** 18.2% 39.8% | 8.1% *** 16.9% 36.7% | 7.5% *** 15.5% 33.3% |
RN hours (Hours 1, 2, 4) (ASH&ED ref: average hours) | 86.0% *** 86.2% 86.6% | 74.1% *** 74.3% 75.1% | ||||
GP hours (Hours 1, 2, 4) (ASH&ED ref: average hours) | 74.8% *** 75.3% 75.4% | 0.4% 0.0% 0.0% |